Dolan ME - Search Results

1

Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.

Trendowski MR, El-Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC Jr, Feldman DR, Ardeshir-Rouhani-Fard S, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann F, Einhorn LH, Fossa SD, Travis LB, Dolan ME. Trendowski MR, et al. Among authors: dolan me. Clin Cancer Res. 2019 Oct 1;25(19):5913-5924. doi: 10.1158/1078-0432.CCR-19-0113. Epub 2019 Jul 11. Clin Cancer Res. 2019. PMID: 31296530 Free PMC article.

2

Sequential therapy with dacarbazine and carmustine: a phase I study.

Mitchell RB, Dolan ME, Janisch L, Vogelzang NJ, Ratain MJ, Schilsky RL. Mitchell RB, et al. Among authors: dolan me. Cancer Chemother Pharmacol. 1994;34(6):509-14. doi: 10.1007/BF00685663. Cancer Chemother Pharmacol. 1994. PMID: 7923562 Clinical Trial.

3

5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis.

Vokes EE, Dolan ME, Krishnasamy S, Mick R, Ratain MJ, Berezin F, Brachman D, Whitman G, Schilsky RL, Charette J, et al. Vokes EE, et al. Among authors: dolan me. Ann Oncol. 1993 Aug;4(7):591-5. doi: 10.1093/oxfordjournals.annonc.a058594. Ann Oncol. 1993. PMID: 8395874 Free article. Clinical Trial.

4

Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.

Vokes EE, Mick R, Kies MS, Dolan ME, Malone D, Athanasiadis I, Haraf DJ, Kozloff M, Weichselbaum RR, Ratain MJ. Vokes EE, et al. Among authors: dolan me. J Clin Oncol. 1996 May;14(5):1663-71. doi: 10.1200/JCO.1996.14.5.1663. J Clin Oncol. 1996. PMID: 8622086 Clinical Trial.

5

Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.

Johnston PG, Mick R, Recant W, Behan KA, Dolan ME, Ratain MJ, Beckmann E, Weichselbaum RR, Allegra CJ, Vokes EE. Johnston PG, et al. Among authors: dolan me. J Natl Cancer Inst. 1997 Feb 19;89(4):308-13. doi: 10.1093/jnci/89.4.308. J Natl Cancer Inst. 1997. PMID: 9048835

6

O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings.

Dolan ME, Roy SK, Fasanmade AA, Paras PR, Schilsky RL, Ratain MJ. Dolan ME, et al. J Clin Oncol. 1998 May;16(5):1803-10. doi: 10.1200/JCO.1998.16.5.1803. J Clin Oncol. 1998. PMID: 9586894 Clinical Trial.

7

O6-benzylguanine and its role in chemotherapy.

Dolan ME, Pegg AE. Dolan ME, et al. Clin Cancer Res. 1997 Jun;3(6):837-47. Clin Cancer Res. 1997. PMID: 9815757 Review.

8

Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.

Gupta E, Olopade OI, Ratain MJ, Mick R, Baker TM, Berezin FK, Benson AB 3rd, Dolan ME. Gupta E, et al. Among authors: dolan me. Clin Cancer Res. 1995 Oct;1(10):1133-8. Clin Cancer Res. 1995. PMID: 9815904

9

Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancer.

Wu MH, Lohrbach KE, Olopade OI, Kokkinakis DM, Friedman HS, Dolan ME. Wu MH, et al. Among authors: dolan me. Clin Cancer Res. 1999 Jan;5(1):209-13. Clin Cancer Res. 1999. PMID: 9918221

10

Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.

Humerickhouse RA, Dolan ME, Haraf DJ, Brockstein B, Stenson K, Kies M, Sulzen L, Ratain MJ, Vokes EE. Humerickhouse RA, et al. Among authors: dolan me. Clin Cancer Res. 1999 Feb;5(2):291-8. Clin Cancer Res. 1999. PMID: 10037177 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page